Published in J Biol Chem on May 30, 2001
High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol (2008) 4.40
Structural determinants and mechanism of HIV-1 genome packaging. J Mol Biol (2011) 1.83
RNA structure and packaging signals in the 5' leader region of the human immunodeficiency virus type 1 genome. J Virol (2002) 1.60
Nucleocapsid protein function in early infection processes. Virus Res (2008) 1.53
The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J Virol (2002) 1.40
Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol (2010) 1.35
Possible role of dimerization in human immunodeficiency virus type 1 genome RNA packaging. J Virol (2003) 1.22
RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor. J Virol (2007) 1.22
Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription. Nat Struct Mol Biol (2010) 1.15
Formation of the tRNALys packaging complex in HIV-1. FEBS Lett (2010) 1.11
Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology (2007) 1.09
Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription. J Virol (2008) 1.05
Roles of Gag and NCp7 in facilitating tRNA(Lys)(3) Annealing to viral RNA in human immunodeficiency virus type 1. J Virol (2009) 1.03
Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription. Viruses (2009) 1.03
Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J Virol (2010) 1.01
Circularization of the HIV-1 RNA genome. Nucleic Acids Res (2007) 1.00
Molecular mimicry of human tRNALys anti-codon domain by HIV-1 RNA genome facilitates tRNA primer annealing. RNA (2012) 0.98
Hairpin-induced tRNA-mediated (HITME) recombination in HIV-1. Nucleic Acids Res (2006) 0.97
Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication. J Virol (2007) 0.97
In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res (2013) 0.96
Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes. J Virol (2004) 0.94
Structural polymorphism of the HIV-1 leader region explored by computational methods. Nucleic Acids Res (2005) 0.94
The structure of the human tRNALys3 anticodon bound to the HIV genome is stabilized by modified nucleosides and adjacent mismatch base pairs. Nucleic Acids Res (2009) 0.94
Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS. RNA (2002) 0.93
Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer. J Virol (2002) 0.93
The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNA. Retrovirology (2004) 0.92
Small-angle X-ray scattering-derived structure of the HIV-1 5' UTR reveals 3D tRNA mimicry. Proc Natl Acad Sci U S A (2014) 0.91
Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation. J Virol (2005) 0.89
Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription. J Virol (2005) 0.88
A sequence similar to tRNA 3 Lys gene is embedded in HIV-1 U3-R and promotes minus-strand transfer. Nat Struct Mol Biol (2009) 0.87
The availability of the primer activation signal (PAS) affects the efficiency of HIV-1 reverse transcription initiation. Nucleic Acids Res (2007) 0.86
Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses. J Virol (2005) 0.86
The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome. PLoS One (2014) 0.85
Does the HIV-1 primer activation signal interact with tRNA3(Lys) during the initiation of reverse transcription? Nucleic Acids Res (2003) 0.85
Initiation of HIV Reverse Transcription. Viruses (2010) 0.85
In vivo SELEX of single-stranded domains in the HIV-1 leader RNA. J Virol (2013) 0.84
Opening of the TAR hairpin in the HIV-1 genome causes aberrant RNA dimerization and packaging. Retrovirology (2012) 0.84
Annealing to sequences within the primer binding site loop promotes an HIV-1 RNA conformation favoring RNA dimerization and packaging. RNA (2013) 0.83
A structure-based mechanism for tRNA and retroviral RNA remodelling during primer annealing. Nature (2014) 0.83
On the importance of the primer activation signal for initiation of tRNA(lys3)-primed reverse transcription of the HIV-1 RNA genome. Nucleic Acids Res (2003) 0.81
Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome. BMC Biol (2004) 0.81
Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy. Mol Ther (2017) 0.80
In virio SHAPE analysis of tRNA(Lys3) annealing to HIV-1 genomic RNA in wild type and protease-deficient virus. Retrovirology (2015) 0.80
Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer. Nucleic Acids Res (2003) 0.80
Role of the primer activation signal in tRNA annealing onto the HIV-1 genome studied by single-molecule FRET microscopy. RNA (2013) 0.79
Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res (2004) 0.79
The Interaction between tRNA(Lys) 3 and the primer activation signal deciphered by NMR spectroscopy. PLoS One (2013) 0.78
The determination of importance of sequences neighboring the Psi sequence in lentiviral vector transduction and packaging efficiency. PLoS One (2012) 0.77
Nucleotides within the anticodon stem are important for optimal use of tRNA(Lys,3) as the primer for HIV-1 reverse transcription. Virology (2007) 0.77
Mutations in the TPsiC loop of E. coli tRNALys,3 have varied effects on in trans complementation of HIV-1 replication. Virol J (2007) 0.77
The role of A-kinase anchoring protein 95-like protein in annealing of tRNALys3 to HIV-1 RNA. Retrovirology (2014) 0.75
Heterogeneous structures formed by conserved RNA sequences within the HIV reverse transcription initiation site. RNA (2016) 0.75
Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 4.66
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J (1996) 3.92
Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol (2000) 2.65
Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol (1995) 2.47
Two alternating structures of the HIV-1 leader RNA. RNA (2001) 2.47
Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis (2005) 2.41
A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol (1999) 1.91
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol (1997) 1.91
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1997) 1.91
Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89
Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J (1994) 1.74
Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains. J Biol Chem (1988) 1.68
Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J Bacteriol (1995) 1.61
Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res (1996) 1.59
Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1990) 1.52
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun (2006) 1.43
Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther (2006) 1.42
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol (1994) 1.41
Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. Gene Ther (2008) 1.40
In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A (2001) 1.40
Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology (1997) 1.39
Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells. Int Immunol (1991) 1.36
The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res (1999) 1.36
Regulation of HIV expression: mechanisms of action of Tat and Rev. AIDS (1991) 1.31
Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res (1994) 1.30
Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1997) 1.28
Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res (1997) 1.27
Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology (1992) 1.26
The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol (1998) 1.25
Determination of the RNA secondary structure that regulates lysis gene expression in bacteriophage MS2. J Mol Biol (1987) 1.24
Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J Virol (1999) 1.22
Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem (1993) 1.22
The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim Biophys Acta (1999) 1.22
Mechanism of translational coupling between coat protein and replicase genes of RNA bacteriophage MS2. Nucleic Acids Res (1985) 1.20
Effect of the sequences upstream from the ribosome-binding site on the yield of protein from the cloned gene for phage MS2 coat protein. Gene (1983) 1.15
The dimer initiation site hairpin mediates dimerization of the human immunodeficiency virus, type 2 RNA genome. J Biol Chem (2001) 1.14
Inhibition of polyadenylation by stable RNA secondary structure. Nucleic Acids Res (1998) 1.14
HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J Mol Biol (1996) 1.14
Inhibiting HIV-1 entry with fusion inhibitors. Curr Med Chem (2003) 1.13
Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther (2008) 1.08
Sequence variation of the human immunodeficiency virus primer-binding site suggests the use of an alternative tRNA(Lys) molecule in reverse transcription. J Gen Virol (1997) 1.07
A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J Virol (1999) 1.06
The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly. Virology (1998) 1.03
Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr (2007) 1.03
Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res (1995) 1.03
Human immunodeficiency virus uses tRNA(Lys,3) as primer for reverse transcription in HeLa-CD4+ cells. FEBS Lett (1994) 1.02
Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res (2001) 1.02
The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol (1995) 1.02
A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome. J Virol (2000) 1.02
HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro. Virology (1999) 1.00
The role of the codon and the initiation factor IF-2 in the selection of N-blocked aminoacyl-tRNA for initiation. Eur J Biochem (1980) 1.00
RNA interference: its use as antiviral therapy. Handb Exp Pharmacol (2006) 0.99
Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription. Nucleic Acids Res (2000) 0.99
Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. J Gen Virol (1998) 0.99
The amino terminal half of the MS2-coded lysis protein is dispensable for function: implications for our understanding of coding region overlaps. EMBO J (1985) 0.97
Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential. AIDS (1999) 0.97
Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1. J Biol Chem (1995) 0.97
Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles. Nucleic Acids Res (2011) 0.97
Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem (1994) 0.97
Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Res Hum Retroviruses (2000) 0.96
Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect. Virology (2001) 0.96
The mechanism of actinomycin D-mediated inhibition of HIV-1 reverse transcription. Nucleic Acids Res (1998) 0.96
Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. J Biol Chem (1992) 0.96
Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther (2006) 0.96
Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant. Virology (1998) 0.94
Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo. Gene Ther (2009) 0.94
On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. AIDS Res Hum Retroviruses (1998) 0.93
Reverse transcriptase fidelity and HIV-1 variation. Science (1997) 0.91
Biased nucleotide composition of the genome of HERV-K related endogenous retroviruses and its evolutionary implications. J Mol Evol (1999) 0.89
A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation. Gene Ther (2011) 0.89
Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res (1997) 0.89
Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007. Biologicals (2008) 0.87
Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell. Virology (1996) 0.86
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J Virol (2000) 0.86
In vitro studies on tRNA annealing and reverse transcription with mutant HIV-1 RNA templates. J Biol Chem (2000) 0.86
Translational interference at overlapping reading frames in prokaryotic messenger RNA. Gene (1985) 0.85
Electroporation of the HIV Tat trans-activator protein into cells. Anal Biochem (1993) 0.84
Formylmethionyl-tRNA binding to 30 S ribosomes programmed with homopolynucleotides and the effect of translational initiation factor 3. Biochim Biophys Acta (1986) 0.84
Antiviral strategies against human coronaviruses. Infect Disord Drug Targets (2007) 0.82
The fidelity of reverse transcription differs in reactions primed with RNA versus DNA primers. J Biomed Sci (1999) 0.79
Similarity of chemokines charge and the V3 domain of HIV-1 env protein. Emerg Infect Dis (1998) 0.79
Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site. J Virol (2001) 0.79
Identification of novel human endogenous retroviral sequences belonging to the HERV-K family. AIDS Res Hum Retroviruses (1998) 0.77
A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus. Gene (1994) 0.76
The restriction enzyme BanI is inhibited by dcm-methylation of the GGCGCm5C site. Nucleic Acids Res (1994) 0.75
Opening the closed ribosome-binding site of the lysis cistron of bacteriophage MS2. Nature (2010) 0.75
Symptomatic osteoarthrosis of the knee: a follow-up study. Br J Rheumatol (1985) 0.75